Merck (MRK) Stock Dips on EPS Outlook Miss, Analysts Still Positive
Tweet Send to a Friend
Merck & Co. (NYSE: MRK) reported a better-than-expected Q4 2021 net income of $3.76 billion, compared to a loss in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
